INVESTMENTS

Explore the investment landscape—from conservative strategies to bold moves. Get expert guidance to build resilient portfolios for long-term growth.

Thyssenkrupp stock news and today’s drivers

Thyssenkrupp stock news and today’s drivers

ASML stock news and drivers today

ASML Holding (NASDAQ: ASML; Euronext Amsterdam: ASML.AS) is trading around $1,093 as of December 15, 2025, up 1.15% on the day. The stock has soared over 55% year-to-date, underpinned by booming AI demand and its monopolistic grip on EUV lithography. Today’s uptick follows a share buyback update and stabilising tech sentiment. However, geopolitical tension over China export controls continues to cap enthusiasm. Investors are watching closely for ASML’s January 2026 outlook, which is expected to address the trajectory of its High-NA tools and Chinese market headwinds.

INVEST NOW >> >

TSMC stock news and today's drivers

Taiwan Semiconductor Manufacturing Company (NYSE: TSM) stock is trading near $291 on December 15, 2025, amid a modest pullback driven by sector-wide AI fatigue and profit-taking. Despite recent volatility, TSMC remains a foundational player in the global semiconductor supply chain, powering the AI chips used by Nvidia, Apple, and AMD. Recent updates show strong monthly revenues, a surging AI backlog, and advanced packaging growth, with production capacity ramping for 3nm and the next-gen 2nm process. Investors remain confident long-term, though near-term sentiment is swayed by macro risks and margin concerns across tech.

INVEST NOW >> >

Broadcom stock news and today’s drivers

Broadcom Inc. (NASDAQ: AVGO) shares are under pressure following its Q4 FY2025 earnings report, despite beating revenue and earnings expectations. As of December 15, 2025, AVGO trades around $341.72, down over 5% intraday and ~18% from its December highs. The post-earnings selloff stems from concerns over falling gross margins, even as AI-related revenue surges. With a $73B AI backlog and growing demand from hyperscalers, long-term fundamentals remain robust. However, investor focus has shifted to profitability mix, sparking a valuation reset across the AI infrastructure space.

INVEST NOW >> >

Novo Nordisk stock news and drivers today

Novo Nordisk (NVO / NOVO-B.CO) has faced a brutal 2025, with shares down over 50% year-to-date, currently trading around $50.63. The once high-flying GLP-1 leader is reeling from pricing challenges, slowing growth, and fierce competition from Eli Lilly’s tirzepatide portfolio. However, pipeline optimism remains: higher-dose Wegovy gained EMA support, Ozempic launched in India at scale, and the $4.7B Akero deal enhances its cardiometabolic pipeline. As of December 15, 2025, Novo Nordisk stock is up 0.9% intraday, as investors recalibrate long-term potential amid sector-wide valuation resets.

INVEST NOW >> >

Novo Nordisk stock news and drivers today

Lipigas stock surges on dividends and growth

Empresas Lipigas S.A. (BCS:LIPIGAS), a top-tier LPG and natural gas distributor in Latin America, is trading near historic highs as of December 15, 2025. The stock has soared over 100% in 2025 alone, now hovering around CLP 8,526, driven by strong earnings, regional growth, and a new interim dividend. Its acquisition in Ecuador and continued dominance in Chile, Peru, and Colombia are reshaping its image from a sleepy utility into a resilient growth play. The upcoming dividend (CLP 153/share, ex-date: Dec 21) is prompting more buying as investors seek exposure to one of the most defensive and rewarding names on the Santiago Stock Exchange. This article unpacks the latest catalysts, trends, and outlook for Lipigas.

INVEST NOW >> >

Lipigas stock surges on dividends and growth

Oracle stock news and what’s driving ORCL today

Oracle (NYSE: ORCL) is currently navigating one of its most volatile periods in recent memory. Despite reporting record-breaking Q2 FY2026 earnings, the stock has dropped sharply, reflecting deep investor concern over high capital expenditures, debt levels, and uncertainty around AI infrastructure execution. As of 15 December 2025, shares are trading around $185.58—down 2.31% on the day and nearly 45% off their September highs. What's driving this paradox? A mix of bullish fundamentals—like a $523 billion backlog—and bearish fears surrounding delayed OpenAI projects, spiralling Capex, and tightening credit markets. This article unpacks what’s really happening with Oracle stock today and where it might be headed next.

INVEST NOW >> >

Oracle stock news and what’s driving ORCL today

What happened with Bitcoin?

November 2025 was a nasty wake-up call for bitcoin bulls. After a euphoric October that pushed BTC to a record near $126,000, the market flipped into full correction mode: price slid from the $109,000-$115,000 consolidation range to lows around $80,500, ETF flows turned sharply negative, and a wave of institutional de-risking and leveraged liquidations crushed sentiment into "extreme fear." By late month, a modest rebound toward the high-$80,000s emerged as ETF outflows eased and traders started to price in a possible Fed rate cut. This overview explains the timeline, the ETF and macro forces behind the dump, and what levels and scenarios serious investors are watching next.

BEST CRYPTO TRADING APP >

What happened with Bitcoin?

What Happened to Novo Nordisk Stock After Its Alzheimer’s Trial Failure

On November 24, 2025, Novo Nordisk’s share price dropped sharply after the company reported that EVOKE and EVOKE+, two phase 3 trials of an oral version of semaglutide in early-stage Alzheimer’s disease, failed to meet their primary endpoint. The stock fell as much as roughly 12% intraday before stabilising, as investors processed what had long been framed as a high-risk “lottery ticket” rather than a core earnings driver. While the news removes a potential blue-sky catalyst, it does not change the core obesity and diabetes story powered by GLP-1 drugs like Ozempic, Wegovy, and Rybelsus. This article walks through the news flow, details what actually went wrong in the trials, and puts the selloff in context of slowing GLP-1 momentum, rising competition from Eli Lilly, U.S. pricing pressure, a CEO transition, and recent layoffs at Novo Nordisk.

TRADE NOVO STOCK >

What happened to Nvidia stock?

Nvidia just answered every “AI bubble” hot take with the loudest earnings print in market history. After a choppy few weeks of China headlines, policy jitters and options-driven selling, the company dropped Q3 FY2026 numbers that didn’t just beat—they obliterated expectations. Revenue jumped to $57.03B, Data Center hit $51.2B, non-GAAP gross margin held 75%, and Q4 guidance at ~$65B revenue effectively told bears to go hug their risk models. The stock ripped over 7% after hours, pushed pre-market above $153 and vaulted Nvidia’s market cap past $5T for the first time. Below, we stitch the full story together: the pre-print drawdown, the “all clear” quarter, and how this resets the narrative, the levels and the risk/reward heading into 2026–2027.

INVEST IN NVIDIA STOCK >

How to invest in Quantum Stocks in the UK

How do you ride the next big wave if you don’t speak quantum—or even want to? Quantum technology is accelerating from research labs into real-world pilots across drug discovery, finance, logistics, and cybersecurity. It has been in the news since 2024, when Google announced that it had developed a functioning quantum chip (which sounded like science fiction to all of us). Even more, the Wall Street Journal reported in October 2025 that the Trump administration was going to partially fund some of the leading names in this high-tech industry.
For investors, the attraction is asymmetric: modest capital can buy exposure to outsized optionality if fault-tolerant systems arrive on schedule. The hazard is equally clear: long R&D cycles, technical bottlenecks, and earnings that lag narrative. This article speaks about all quantum-related investments.

INVEST IN QUANTUM STOCKS >

Scott Bessent vs UK's Sterling Pound

This is a real, data-driven account of Scott Bessent’s ascent from Yale graduate to a leading member of George Soros’s London team, the group that famously shorted the pound sterling in 1992. We explain how the ERM’s rigid rules, Germany’s high rates, and Britain’s weak growth set up an asymmetric trade; how execution across banks, forwards and options amplified the move; and how risk control—not bravado—kept the position solvent while the Bank of England fired its volleys. We then track Bessent through subsequent macro campaigns and into Key Square, before concluding with how that trader’s discipline translates into his present-day stewardship in public office. It’s the craft, not the legend—told plainly, with lessons you can use.

INVEST IN US STOCKS >

What happened to Ørsted share price?

Ørsted A/S (ORSTED.CO), once Europe’s offshore wind crown jewel, has seen its share price collapse in 2025. Trading at just 117 DKK as of 9 November, it has fallen 64% year-to-date and nearly 68% over the past 12 months. The decline stems from a toxic combination of U.S. political opposition to renewables, major project write-downs, dilutive financing, and structural headwinds across the clean energy sector. While a £6.5 billion UK asset sale brought temporary relief, and shares briefly rallied post-Q3 earnings, the long-term picture remains grim. Once soaring at 778 DKK in early 2021, the stock has shed over 80% in five years, a stark reversal for the Danish wind leader. Analysts remain wary despite a derisked balance sheet, and Ørsted’s fair value estimate suggests it’s still trading at a premium — raising questions about its near-term upside.

INVEST IN ØRSTED TODAY >

What happened with Atos stock?

Atos SE (ticker: ATO.PA), one of France’s leading digital transformation and IT firms, has seen its stock experience one of the most dramatic turnarounds in recent European market history. From losing over 98.5% of its value between 2021 and 2024 to staging a modest recovery in 2025, the company’s journey has been turbulent. Burdened by €4.8 billion in debt and weakened by failed acquisitions, Atos faced near-bankruptcy before government intervention and a sweeping restructuring effort. A 1-for-10,000 reverse stock split in April 2025 reset its capital structure and brought short-term technical stability. By November 2025, the stock had doubled year-to-date, though it remains highly volatile. Analysts are divided—some see lingering structural risk, while others believe Atos could be a deep-value recovery play. The company’s success now hinges on debt reduction, operational discipline, and renewed investor trust.

INVEST IN ATOS NOW >

Risk comes from not knowing what you are doing.
Warren Buffett